Wellington Management Group LLP Novo Cure LTD Transaction History

Wellington Management Group LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $13,307 - $34,896	-824 Reduced 1.1%	74,001 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $3.01 Million - $6.17 Million	74,825 New	74,825 $3.11 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $85.6 Million - $133 Million	-762,811 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $58.4 Million - $112 Million	-1,006,718 Reduced 56.89%	762,811 $84.9 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $46.2 Million - $60.1 Million	807,659 Added 83.97%	1,769,529 $105 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $5.68 Million - $9.53 Million	99,520 Added 11.54%	961,870 $64.8 Million
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $58.9 Million - $80.9 Million	862,350 New	862,350 $72.7 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.